May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Corneal Epithelial-Enriched MicroRNAs Combine to Regulate the Lipid Phosphatase SHIP2: A Novel Paradigm for MicroRNA Function
Author Affiliations & Notes
  • J. Yu
    Dermatology, Northwestern University, Chicago, Illinois
  • D. G. Ryan
    Dermatology, Northwestern University, Chicago, Illinois
  • M. Oliveira-Fernandes
    Dermatology, Northwestern University, Chicago, Illinois
  • A. Fatima
    Dermatology, Northwestern University, Chicago, Illinois
  • R. M. Lavker
    Dermatology, Northwestern University, Chicago, Illinois
  • Footnotes
    Commercial Relationships  J. Yu, None; D.G. Ryan, None; M. Oliveira-Fernandes, None; A. Fatima, None; R.M. Lavker, None.
  • Footnotes
    Support  NIH Grant EY017536
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 5043. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Yu, D. G. Ryan, M. Oliveira-Fernandes, A. Fatima, R. M. Lavker; Corneal Epithelial-Enriched MicroRNAs Combine to Regulate the Lipid Phosphatase SHIP2: A Novel Paradigm for MicroRNA Function. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5043.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : MicroRNAs (miRNAs) play important regulatory roles in development, differentiation, cellular stress responses and cancer. We reported that miRNA-184 (mir-184) was the most abundant corneal epithelial miRNA; mir-205 was the second most abundant. We have identified a common target of mir-184 and -205 activity and show a unique regulatory role for mir-184.

Methods: : We used luciferase reporter assays in HeLa cells to validate potential targets of mir-184 and -205 identified by bioinformatics. To confirm these findings we conducted gain- and loss-of-function experiments with mir-184 and -205 in HeLa cells and human keratinocytes, in conjunction with Northern, Western, and immunohistochemical analyses.

Results: : We screened for targets to mir-184 and -205. Marked reduction (>60%) in luciferase activity was seen in cells co-transfected with mir-205 and a reporter construct carrying the 3’UTR for SHIP2. To validate SHIP2 as a target of mir-205, we used a mir-205 mimic to knock-down SHIP2 in HeLa cells, which have negligible endogenous levels of mir-205. Treatment with the mir-205 mimic resulted in a marked reduction in endogenous SHIP2 expression on Western blots, while a non-targeting mimic had no effect. Similarly, SHIP2 staining was markedly diminished after transfection with the mir-205 mimic. To test whether mir-205 regulates SHIP2 in keratinocytes, we used an antagomir to mir-205 (anti-mir-205). We determined by Northern analysis that anti-mir-205 could down-regulate mir-205 in cultured keratinocytes, and that such a treatment resulted in a marked increase in SHIP2 staining when compared with cells treated with anti-mir124 (an irrelevant antagomir). Bioinformatics indicates that only mir-184 and -205 are potential regulators of SHIP2. Interestingly, no reduction in luciferase activity for the SHIP2 construct was observed in HeLa cells co-transfected with mir-184; however, co-transfection of both mir-184 and -205 inhibited mir-205-mediated downregulation of the luciferase activity for the SHIP2 construct. Mutation of the bases required for mir-184 and -205 binding on the SHIP2 molecule revealed that mir-184 negatively regulates the activity of mir-205 on SHIP2.

Conclusions: : These findings establish that: (i) SHIP2, which is a negative regulator of the PI3K-PKB/AKT pathway, is directly regulated by mir-205; and (ii) mir-205 undergoes a unique form of regulation in the corneal epithelium through an interaction with the corneal-specific mir-184. This is the first demonstration that one miRNA plays a major role as a negative regulator of another miRNA.

Keywords: cornea: epithelium • development • signal transduction 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×